top of page

Our “Negligence” Emails Make National News

Every week since April 2024, The Angry Moms has published emails titled “Clozapine REMS – Negligence of the Week” with heartbreaking highlights from submissions to our website and social media outlets.

 

Senior reporter Mark Moran has published a story on our “Negligence” emails and our efforts to end the clozapine REMS in the October 2024 edition of Psychiatric News. Read his article here:

 

 

Thank you, Mark, for publicizing our struggles. Thank you to Dr. Robert Laitman and Dr. Robert Cotes for contributing to the publication and for acknowledging the plight of The Angry Moms.

 

Our “Negligence” reports are certainly biased and skewed. Our community represents a very small subset of the schizophrenia and psychosis population who are capable of connecting to websites and verbalizing problems. Our stories and vignettes are limited to those with engaged and connected caregivers willing to research, willing to drive, make phone calls, chase down lab orders, argue with pharmacists, and make frequent calls to the REMS hotline. These are families and agencies willing to fight to keep their family members and patients on uninterrupted clozapine treatment.

 

The reality is far worse than our “Negligence” emails. Most individuals with these illnesses are too cognitively impaired or disenfranchised to recognize medical negligence is happening. Such patients are wrongly interrupted, wrongly discontinued, or worse – refused clozapine treatment in the first place. Many such individuals have died and cannot share their story of negligence. The FDA does not track or record these regulation-induced adverse events.

 

As far as we know, The Angry Moms is the only group reporting such events. Incredibly, this task has fallen on exhausted and unpaid mothers to figure out, rather than agencies and corporations professionally tasked with monitoring psychiatric medications and treatment.

 

The Angry Moms has encountered a handful of true cases of clozapine-induced neutropenia (most alleged cases have been “false positives” or unrelated to clozapine). These few instances were indeed serious life-threatening events. But NOT ONE of these cases averted severe illness or death because someone pulled up to a pharmacy window and the pharmacist refused to dispense clozapine because the REMS had blocked a refill. In each case, either the patient had become ill, or a clinician intervened upon receipt of the laboratory report.

 

The REMS appears to be exclusively blocking prescription refills for individuals who do not have clozapine-induced severe neutropenia. Please reach out to The Angry Moms and tell us if you have experienced a true case of severe neutropenia, confirmed associated with clozapine, that was first detected, thereby saving a life, because the clozapine REMS specifically blocked a dispense authorization and a pharmacy refused to fill the prescription. We have yet to encounter a single clozapine REMS victory.

 

Clozapine patients should be monitored carefully, for all potential clozapine-related side effects, with as close to weekly ANC measurements as possible during the first 18 weeks of treatment. Unless, of course, the testing itself presents a barrier to treatment. The risk of developing severe neutropenia is only 1 in 250 clozapine patients. The condition is rarely fatal, ultimately leading to less than 5 deaths in 10,000 clozapine patients. On the other hand, the likelihood of death or severe consequences from untreated psychosis or recurrent suicidal behavior without clozapine treatment is several hundred times higher.

 

For a detailed summary of this research, refer to our 9/26 petition to make safety revisions to the clozapine product label and to end the clozapine REMS. Please sign and share: 

 

 

There are humane ways to track and monitor patients: finger-stick ANC devices, frequent clinical visits, and checking for fever, signs of infection, and overall wellness. A skilled provider and strong patient support are essential.

 

Clozapine patients and their families are held hostage by an outdated product label and regulatory barriers that are outright cruel. The clozapine REMS is intended to be a patient “safety program.” It is not. It is a health hazard that must be eliminated.


The Angry Moms



9 Comments


Guest
Oct 11

I am a retired infectious diseases internist who has a son with schizophrenia. Clozapine has been a god-send but helping my son not to miss doses because of the restrictions around its use has been difficult even for me; the restrictions are poorly conceived, excessive and dangerous. This kind of approach is not used for the many other drugs with a higher risk of serious side effects. It is past time for this situation to change.

Like

Guest
Oct 11

I am a patient and clozapine has changed my life! The only challenging part is the monthly blood draw. And also jumping through hoops trying to get the blood work results to pharmacy in a timely fashion. I would love to support this cause!

Like

Guest
Oct 11

I am a mother of a 32 yr old son that has schizoaffective. My son was not given or really offered clozapine until he had exhausted at least 7 other medications. Additionally, getting refills has been a trial although we have complied with 6 months of weekly bloodwork. I hope that something can be done to make getting life changing medication easier for the people who suffer and have done so for an average of 10 years.

Like

Guest
Oct 11

I am a mom and caregiver of a 33 year old son with schizoaffective disorder and he is on Clozapine. Just today, even after my son being on the medication since 2017, we still had a problem and much aggravation from doing bloodwork and making sure it is received by the physician and onto the pharmacy. I am sick and tired of all the phone calls and emails and after spending all day on this, the pharmacy has still not been able to fill the prescription refill for my son. I will be dealing with this again tomorrow. My son has never had a problem with his white blood count after being on it six years, but we have had…

Like

Guest
Oct 11

I am a caregiver for my son. I have had difficulty due to complication with REMS for five years, hand delivering blood tests to the pharmacy. Recently the doctor reported the wrong neutrophil count and my son was not allowed his medication. I called REMS. The REMS program is detrimental to the continuity of care.

Like
bottom of page